Abbott Labs Settles Pregnancy Bias Suit With Laid-Off Employee
Abbott Laboratories agreed to settle claims from a laid-off worker that the company engaged in pregnancy discrimination by ...
Abbott and DexCom settle glucose monitor patent disputes
Abbott Laboratories and DexCom said on Monday they have reached an agreement to settle all patent disputes between them ...
Abbott Laboratories stock rises Tuesday, still underperforms market
Shares of Abbott Laboratories ABT inched 0.39% higher to $114.76 Tuesday, on what proved to be an all-around positive trading ...
Abbott Whistleblower's False Claims Suit is Revived, Narrowed
A federal appeals court trimmed a whistleblower’s once-defeated False Claims Act suit Friday alleging Abbott Laboratories Inc ...
Barchart on MSN10d
How Abbott Labs Became a Dividend Growth Investor's Dream
Abbott is one of the biggest healthcare companies in the world. With over 400 consecutive quarterly dividend payouts and 53 ...
Abbott Laboratories: A Future-Driven Pharma Brand With A Robust Pipeline
Abbott Laboratories is rated a Buy due to growth indicators, diversified portfolio, strong profit margin. Read an investment ...
bovnews2d
Abbott Laboratories (ABT)’s Stock Surge: What You Need to Know
Abbott Laboratories (ABT) stock saw a modest uptick, ending the day at $114.23 which represents a slight increase of $1.81 or 1.61% from the prior close of $112.42. The stock opened at $112.64 and ...
Abbott, DexCom settlement ‘not a complete surprise,’ says Wells Fargo
Wells Fargo notes Abbott (ABT) and DexCom (DXCM) have disclosed that on December 20, they settled and entered into a cross-license agreement to ...
DexCom, Abbott agree to settle patent litigation
As previously disclosed, DexCom has been involved in global patent litigation with Abbott Diabetes Care and its affiliates. Both the Comp ...
M&T Bank Corp Has $110.42 Million Stock Position in Abbott Laboratories (NYSE:ABT)
M&T Bank Corp lessened its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 6.3% during the 3rd quarter, ...
Reuters3d
Abbott and DexCom settle glucose monitor patent disputes
Dec 23 (Reuters) - Abbott Laboratories (ABT.N), opens new tab and DexCom (DXCM.O), opens new tab said on Monday they have reached an agreement to settle all patent disputes between them related to ...